Single-arm oncology trials and the nature of external controls arms

被引:12
|
作者
Hashmi, Mustafa [1 ]
Rassen, Jeremy [2 ]
Schneeweiss, Sebastian [1 ,2 ,3 ]
机构
[1] Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon, Dept Med, Boston, MA 02120 USA
[2] Aetion Inc, Boston, MA 02109 USA
[3] Harvard Med Sch, Boston, MA 02115 USA
关键词
adaptive clinical trials; clinical trials; nonrandomized trials; oncology; real-world evidence; trial design; CELL LUNG-CANCER; COMPARATIVE EFFICACY; BEVACIZUMAB; NSCLC;
D O I
10.2217/cer-2021-0003
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Aim: Single-arm trials with external control arms (ECAs) have gained popularity in oncology. ECAs may consist of primary data from previous trials, electronic health records (EHRs) or aggregate data from the literature. We sought to provide a description of how such studies achieve similarity of patients, comparability of data quality and outcome assessment. Materials & methods: In a stratified convenience sample of 15 studies, five used primary data from trials as ECAs, five used secondary data from EHRs and five used aggregate data from the literature. Data were collected from the published literature and public web resources, blinded to the eventual approval decision. Results: Studies using ECAs from primary data and EHR data displayed methods to achieve comparability of information, including matched baseline characteristics. Aggregate data from published studies did not attempt to match covariates. The EHR controls often showed calendar time overlap for collecting information while trial data were mostly historic. Outcome data were not consistently reported across studies. US FDA approval was only seen when primary data from trials or EHR data were used as the ECA, however no ECA in this sample directly contributed to approval. Discussion: In this nonsystematic review of ECAs for single-arm trials, the ECAs derived from primary data collected by other trials or EHRs show patterns of patient comparability, time overlap, and realistic methodological approaches to achieving balance between treatment arms. They are often submitted to regulators while literature-derived aggregate findings as ECA may serve as benchmarks for pipeline decisions.
引用
收藏
页码:1053 / 1066
页数:14
相关论文
共 50 条
  • [21] NICE RECONSIDERATION FOR ONCOLOGY DRUGS BASED ON SINGLE-ARM TRIALS REFERRED TO CANCER DRUG FUND
    Wu, S.
    Zou, D.
    Zhang, E.
    [J]. VALUE IN HEALTH, 2024, 27 (06) : S119 - S119
  • [22] Single-arm Trials with Historical Controls Study Designs to Avoid Time-related Biases
    Suissa, Samy
    [J]. EPIDEMIOLOGY, 2021, 32 (01) : 94 - 100
  • [23] UNRAVELLING THE RATIONALE FOR THE SOURCE OF EXTERNAL CONTROL ARM IN SINGLE-ARM ONCOLOGY SUBMISSIONS: WHAT IS THE JUSTIFICATION BEHIND THE MAZE OF OPTIONS?
    Rizzo, M.
    Garcia, A.
    Appiah, K.
    Hernandez, L. G.
    Sarri, G.
    [J]. VALUE IN HEALTH, 2022, 25 (07) : S513 - S513
  • [24] COMPARATIVE EFFECTIVENESS USING EXTERNAL CONTROLS FOR SINGLE-ARM TRIALS OF PEMBROLIZUMAB IN TUMOR-AGNOSTIC INDICATIONS LEVERAGING REAL-WORLD DATA
    Chen, Y.
    Martin, P.
    Ye, S.
    Inoue, L.
    Basu, A.
    Carlson, J. J.
    [J]. VALUE IN HEALTH, 2023, 26 (06) : S363 - S364
  • [25] Isotonic design for single-arm biomarker stratified trials
    Li, Lang
    Ivanova, Anastasia
    [J]. STATISTICAL METHODS IN MEDICAL RESEARCH, 2024, 33 (06) : 945 - 952
  • [26] Adaptive sequential design for phase II single-arm oncology trials: an expansion of Simon's design
    Gao, Ping
    Zhang, Weidong
    [J]. JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2024,
  • [27] Single-arm clinical trials: design, ethics, principles
    Wang, Minyan
    Ma, Huan
    Shi, Yun
    Ni, Haojie
    Qin, Chu
    Ji, Conghua
    [J]. BMJ SUPPORTIVE & PALLIATIVE CARE, 2024,
  • [28] Historical Controls for Metastatic Pancreatic Cancer: Benchmarks for Planning and Analyzing Single-Arm Phase II Trials
    Philip, Philip A.
    Chansky, Kari
    LeBlanc, Michael
    Rubinstein, Lawrence
    Seymour, Lesley
    Ivy, S. Percy
    Alberts, Steven R.
    Catalano, Paul J.
    Crowley, John
    [J]. CLINICAL CANCER RESEARCH, 2014, 20 (16) : 4176 - 4185
  • [29] External control arms to contextualise single arm clinical trials - propensity score methods can be inconsistent
    Peach, Emily J.
    Khosla, Sajan
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2021, 30 : 226 - 227
  • [30] Proprioceptive Interaction between the Two Arms in a Single-Arm Pointing Task
    Kigawa, Kazuyoshi
    Izumizaki, Masahiko
    Tsukada, Setsuro
    Hakuta, Naoyuki
    [J]. PLOS ONE, 2015, 10 (08):